Topics

FDA grants fast track status to Moderna’s Zika vaccine

04:04 EDT 20 Aug 2019 | Pharmaceutical Business Review

At present, the mRNA-1893 vaccine is being assessed in a phase 1 study to prevent Zika virus infection in healthy adults. The mRNA-1893 included an mRNA sequence that

The post FDA grants fast track status to Moderna’s Zika vaccine appeared first on Pharmaceutical Business review.

Original Article: FDA grants fast track status to Moderna’s Zika vaccine

NEXT ARTICLE

More From BioPortfolio on "FDA grants fast track status to Moderna’s Zika vaccine"

Quick Search

Relevant Topics

Vaccines
A vaccine is any preparation intended to produce immunity to a disease by stimulating the production of antibodies. It creates immunity but does not cause the disease. There are several differnt types of vaccine avalable; Killed microorganisms; which s...

Infectious-diseases
Antiretroviral Therapy Clostridium Difficile Ebola HIV & AIDS Infectious Diseases Influenza Malaria Measles Sepsis Swine Flu Tropical Medicine Tuberculosis Infectious diseases are caused by pathogenic...